Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1995The Journal of Clinical Endocrinology & Metabolism

Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata.

View Full Paper
Ask AI
Bookmark
Share

Authors

TVThanh VuVietnam Posts and Telecommunications Group (Vietnam)CYClaudine M. YballeJoslin Diabetes CenterSBS BoonyanitVA Palo Alto Health Care System

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vu et al. (1995) studied this question.

synapsesocial.com/papers/6a97274931394ac286fbf185https://doi.org/10.1210/jcem.80.5.7745016
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The product of the H19 gene may function as an RNA.1990 · 1,072 citations
  2. 2The human insulin‐like growth factor II gene contains two development‐specific promoters1987 · 171 citations
  3. 3Physiology: Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata1993 · 135 citations